Target intelligence / Profile preview

Respiratory syncytial virus fusion protein, nucleoprotein, and M2-1 protein (RSV F, N, and M2-1)

Target
RSV F, N, and M2-1
Molecular classification
Viral fusion protein, Class I viral fusion protein, Viral nucleocapsid protein, Viral transcription factor, Transcription antiterminator, RNA-binding protein
01

Overview

The Respiratory syncytial virus fusion protein (F protein) is a class I viral fusion protein that mediates the merger of viral and cellular membranes, enabling viral entry into host cells. The RSV nucleoprotein (N protein) forms the structural core of the ribonucleoprotein complex by encapsidating the viral genome, protecting RNA from degradation, and serving as a template for RNA synthesis. The RSV M2-1 protein is a transcription antiterminator and processivity cofactor for the viral RNA-dependent RNA polymerase, enabling synthesis of full-length mRNA transcripts and interacting with both viral and host RNAs. All three proteins are essential for RSV replication, play unique roles in the viral life cycle, and are considered validated or investigational therapeutic targets, primarily for the prevention or treatment of RSV infection.

Other names
RSV F proteinFusion proteinRSV N proteinNucleoproteinNucleocapsid proteinRSV M2-1 protein
02

Mechanism of action

Inhibition of F protein prevents viral entry into host cells by blocking fusion; inhibition of M2-1 protein disrupts viral transcription, blocking production of viral mRNAs; inhibition of N protein would disrupt viral RNA encapsidation and replication.

03

Biological functions

Mediates viral and host cell membrane fusionEnables viral entryEncapsidates the viral RNA genomeEssential for genome protection and replicationTranscription antiterminatorIncreases RNA polymerase processivityBinds viral and some cellular RNAsInteracts with the RSV polymerase complex
04

Disease associations

Essential for the replication and pathogenesis of human respiratory syncytial virus (RSV), a major cause of respiratory tract infections, particularly in infants and elderly
05

Safety considerations

Antibody therapies against F protein can rarely produce hypersensitivity reactionsOff-target effects possible with small molecule inhibitors targeting viral proteins (under investigation)Resistance mutations may emerge in F protein under therapeutic pressure
06

Interacting drugs

Palivizumab

4 more in the full profile.

07

Biomarkers

Detection of RSV F, N, and M2-1 proteins or their mRNA in respiratory samples

Beyond the preview

Go deeper on Respiratory syncytial virus fusion protein, nucleoprotein, and M2-1 protein (RSV F, N, and M2-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Respiratory syncytial virus fusion protein, nucleoprotein, and M2-1 protein (RSV F, N, and M2-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call